Donor T-cell-mediated pancytopenia after haploidentical hematopoietic stem cell transplant for severe combined immunodeficiency

J Pediatr Hematol Oncol. 2009 Feb;31(2):148-50. doi: 10.1097/MPH.0b013e3181979c4a.

Abstract

Haploidentical hematopoietic stem cell transplant with T-cell depletion may result in donor T-cell engraftment in infants with severe combined immunodeficiency disease. Engraftment of other hematopoietic lines is achieved rarely, and pancytopenia and hemophagocytosis as a result of donor T-cell engraftment have not been reported. We report an infant with severe combined immunodeficiency who developed graft versus host disease with pancytopenia as a result of engraftment of maternal T cells after T-depleted hematopoietic stem cell transplant. His pancytopenia resolved after thymoglobulin and a stem cell boost. Thrombocytopenia resolved with rituximab.

Publication types

  • Case Reports

MeSH terms

  • Graft Survival
  • Graft vs Host Disease
  • Haplotypes
  • Hematopoietic Stem Cell Transplantation / adverse effects
  • Hematopoietic Stem Cell Transplantation / methods*
  • Humans
  • Infant
  • Male
  • Pancytopenia / therapy*
  • Severe Combined Immunodeficiency / therapy*
  • T-Lymphocytes / physiology*
  • T-Lymphocytes / transplantation
  • Treatment Outcome